Total Payments
$7,712
2024 Payments
$3,166
Companies
24
Transactions
392
Medicare Patients
976
Medicare Billing
$68,066
Payment Breakdown by Category
Food & Beverage$7,432 (96.4%)
Education$279.98 (3.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,432 | 389 | 96.4% |
| Education | $279.98 | 3 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,053 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $1,034 | 34 | $0 (2024) |
| Dermavant Sciences, Inc. | $807.98 | 46 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $617.16 | 26 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $551.00 | 42 | $0 (2024) |
| PFIZER INC. | $505.18 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $498.07 | 30 | $0 (2024) |
| GENZYME CORPORATION | $434.72 | 16 | $0 (2024) |
| Incyte Corporation | $367.31 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $347.40 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,166 | 167 | Dermavant Sciences, Inc. ($434.40) |
| 2023 | $2,336 | 119 | Janssen Biotech, Inc. ($361.23) |
| 2022 | $1,445 | 67 | ABBVIE INC. ($347.55) |
| 2021 | $765.59 | 39 | Janssen Biotech, Inc. ($278.36) |
All Payment Transactions
392 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.18 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Dermatology | ||||||
| 11/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.86 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $49.18 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $131.45 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $53.70 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: DERMATOLOGY | ||||||
| 11/08/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 316 | 501 | $91,850 | $20,546 |
| 2022 | 11 | 410 | 573 | $117,115 | $29,153 |
| 2021 | 8 | 250 | 441 | $71,945 | $18,368 |
Total Patients
976
Total Services
1,515
Medicare Billing
$68,066
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 86 | $16,770 | $5,310 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $8,250 | $2,597 | 31.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 21 | 27 | $13,500 | $2,220 | 16.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 34 | 48 | $14,400 | $1,918 | 13.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 25 | 26 | $9,100 | $1,763 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 41 | $6,150 | $1,602 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,900 | $1,339 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $3,150 | $1,298 | 41.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $4,950 | $1,039 | 21.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 20 | 158 | $7,900 | $797.79 | 10.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 16 | $3,600 | $650.04 | 18.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 18 | $180.00 | $12.65 | 7.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 132 | $25,740 | $9,022 | 35.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 37 | 47 | $23,500 | $4,383 | 18.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 48 | 48 | $12,000 | $3,868 | 32.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 37 | 39 | $13,650 | $3,193 | 23.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 61 | $9,225 | $2,739 | 29.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 36 | 46 | $13,800 | $2,037 | 14.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 25 | 25 | $5,625 | $1,377 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 17 | $3,825 | $1,293 | 33.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 25 | 129 | $6,450 | $695.68 | 10.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 13 | 14 | $3,150 | $535.28 | 17.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 15 | $150.00 | $9.72 | 6.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 71 | $13,845 | $5,259 | 38.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 29 | 29 | $7,250 | $2,509 | 34.6% |
About Yaroslav Yanishin
Yaroslav Yanishin is a Physician Assistant healthcare provider based in Garden City, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2017. The National Provider Identifier (NPI) number assigned to this provider is 1083127799.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yaroslav Yanishin has received a total of $7,712 in payments from pharmaceutical and medical device companies, with $3,166 received in 2024. These payments were reported across 392 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($7,432).
As a Medicare-enrolled provider, Yanishin has provided services to 976 Medicare beneficiaries, totaling 1,515 services with total Medicare billing of $68,066. Data is available for 3 years (2021–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Student in an Organized Health Care Education/Training Program, Physician Assistant
- Location Garden City, NY
- Active Since 11/16/2017
- Last Updated 07/14/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1083127799
Products in Payments
- TREMFYA (Drug) $1,159
- DUPIXENT (Biological) $1,052
- VTAMA (Drug) $807.98
- SKYRIZI (Biological) $617.55
- Winlevi (Drug) $551.00
- Sotyktu (Drug) $482.61
- OPZELURA (Drug) $367.31
- EUCRISA (Drug) $361.03
- Otezla (Drug) $273.64
- RINVOQ (Biological) $271.04
- COSENTYX (Drug) $206.73
- TALTZ (Drug) $193.02
- Zoryve (Drug) $192.34
- HUMIRA (Biological) $164.52
- CIBINQO (Drug) $144.15
- AMELUZ (Drug) $119.85
- OLUMIANT (Drug) $96.47
- AMZEEQ (Drug) $65.51
- ADBRY (Biological) $59.98
- YCANTH (Drug) $46.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Garden City
Miss. Melissa White, Rpa-C, RPA-C
Physician Assistant — Payments: $246,814
Physician Assistant $246,814
Ms. Sari Katz, Ms,Pa-C, MS,PA-C
Physician Assistant — Payments: $237,387
Physician Assistant $237,387
Patrycja Szczepanek, Pa, PA
Physician Assistant — Payments: $14,771
Physician Assistant $14,771
Miss. Katie Madlen, Pa-C, PA-C
Physician Assistant — Payments: $10,960
Physician Assistant $10,960
Pamela Lachs, Pa-C, PA-C
Physician Assistant — Payments: $10,593
Physician Assistant $10,593
Carmine Vacchio, Rpa-C, RPA-C
Physician Assistant — Payments: $8,152
Physician Assistant $8,152